Jump Financial’s Sarepta Therapeutics SRPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.1M	Buy	507,828 +338,931	+201%	+$6.56M	0.16%	154
2025 Q4	$3.63M	Sell	168,897 -132,112	-44%	-$2.78M	0.05%	467
2025 Q3	$5.8M	Sell	301,009 -302,260	-50%	-$5.39M	0.07%	366
2025 Q2	$10.3M	Buy	603,269 +597,484	+10,328%	+$25.5M	0.13%	233
2025 Q1	$369K	Buy	5,785 +3,967	+218%	+$418K	0.01%	1203
2024 Q4	$221K	Buy	+1,818	New	+$223K	﹤0.01%	1446
2024 Q3	–	Sell	-52,700	Closed	-$8.33M	–	2088
2024 Q2	$8.33M	Buy	+52,700	New	+$6.77M	0.17%	113
2024 Q1	–	Sell	-14,077	Closed	-$1.36M	–	2281
2023 Q4	$1.36M	Buy	+14,077	New	+$1.35M	0.04%	551
2023 Q3	–	Sell	-16,200	Closed	-$1.86M	–	2235
2023 Q2	$1.86M	Buy	16,200 +12,587	+348%	+$1.62M	0.07%	422
2023 Q1	$498K	Sell	3,613 -34,282	-90%	-$4.45M	0.02%	895
2022 Q4	$4.91M	Sell	37,895 -25,105	-40%	-$2.91M	0.26%	100
2022 Q3	$6.96M	Buy	63,000 +703	+1%	+$70.9K	0.27%	52
2022 Q2	$4.67M	Buy	+62,297	New	+$4.58M	0.2%	125
2022 Q1	–	Sell	-5,055	Closed	-$455K	–	1892
2021 Q4	$455K	Buy	+5,055	New	+$432K	0.03%	696
2021 Q2	–	Sell	-9,410	Closed	-$701K	–	1373
2021 Q1	$701K	Buy	+9,410	New	+$868K	0.07%	317
2020 Q4	–	Sell	-3,560	Closed	-$500K	–	1165
2020 Q3	$500K	Buy	+3,560	New	+$541K	0.1%	330